Acer Therapeutics Inc. - FORM 8-K - EX-16.1 - LETTER ON CHANGE IN CERTIFYING ACCOUNTANT - September 20, 2017

Attached files

file filename
EX-3.1 - CERTIFICATE OF AMENDMENT OF CERTIFICATE OF FORMATION OF THE REGISTRANT. - Acer Therapeutics Inc.acer_ex31.htm
EX-99.1 - PRESS RELEASE ISSUED BY THE REGISTRANT ON SEPTEMBER 19, 2017 - Acer Therapeutics Inc.acer_ex991.htm
EX-10.3 - ACER THERAPEUTICS INC. 2013 STOCK INCENTIVE PLAN. - Acer Therapeutics Inc.acer_ex103.htm
EX-3.2 - CERTIFICATE OF AMENDMENT OF CERTIFICATE OF FORMATION OF THE REGISTRANT. - Acer Therapeutics Inc.acer_ex32.htm
8-K - CURRENT REPORT - Acer Therapeutics Inc.acer_8k.htm
 
  Exhibit 16.1
 
 
September 20, 2017
 
 
 
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
 
 
We have read the statements under Item 4.01 of the Current Report on Form 8-K of Acer Therapeutics Inc. to be filed with the Securities and Exchange Commission on or about September 20, 2017. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other statements contained therein.
 
 
MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
 
 
 

Acer Therapeutics Inc. Reports